Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation

View through CrossRef
Kallistatin was identified in human plasma as a tissue kallikrein‐binding protein and a serine proteinase inhibitor. Kallistatin exerts pleiotropic effects on angiogenesis, oxidative stress, inflammation, apoptosis, fibrosis, and tumor growth. Kallistatin levels are markedly reduced in patients with coronary artery disease, sepsis, diabetic retinopathy, inflammatory bowel disease, pneumonia, and cancer. Moreover, plasma kallistatin levels are positively associated with leukocyte telomere length in young African Americans, indicating the involvement of kallistatin in aging. In addition, kallistatin treatment promotes vascular repair by increasing the migration and function of endothelial progenitor cells (EPCs). Kallistatin via its heparin‐binding site antagonizes TNF‐α‐induced senescence and superoxide formation, while kallistatin’s active site is essential for inhibiting miR‐34a synthesis, thus elevating sirtuin 1 (SIRT1)/eNOS synthesis in EPCs. Kallistatin inhibits oxidative stress‐induced cellular senescence by upregulating Let‐7g synthesis, leading to modulate Let‐7g‐mediated miR‐34a‐SIRT1‐eNOS signaling pathway in human endothelial cells. Exogenous kallistatin administration attenuates vascular injury and senescence in association with increased SIRT1 and eNOS levels and reduced miR‐34a synthesis and NADPH oxidase activity, as well as TNF‐α and ICAM‐1 expression in the aortas of streptozotocin‐ (STZ‐) induced diabetic mice. Conversely, endothelial‐specific depletion of kallistatin aggravates vascular senescence, oxidative stress, and inflammation, with further reduction of Let‐7g, SIRT1, and eNOS and elevation of miR‐34a in mouse lung endothelial cells. Furthermore, systemic depletion of kallistatin exacerbates aortic injury, senescence, NADPH oxidase activity, and inflammatory gene expression in STZ‐induced diabetic mice. These findings indicate that endogenous kallistatin displays a novel role in protection against vascular injury and senescence by inhibiting oxidative stress and inflammation.
Title: Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation
Description:
Kallistatin was identified in human plasma as a tissue kallikrein‐binding protein and a serine proteinase inhibitor.
Kallistatin exerts pleiotropic effects on angiogenesis, oxidative stress, inflammation, apoptosis, fibrosis, and tumor growth.
Kallistatin levels are markedly reduced in patients with coronary artery disease, sepsis, diabetic retinopathy, inflammatory bowel disease, pneumonia, and cancer.
Moreover, plasma kallistatin levels are positively associated with leukocyte telomere length in young African Americans, indicating the involvement of kallistatin in aging.
In addition, kallistatin treatment promotes vascular repair by increasing the migration and function of endothelial progenitor cells (EPCs).
Kallistatin via its heparin‐binding site antagonizes TNF‐α‐induced senescence and superoxide formation, while kallistatin’s active site is essential for inhibiting miR‐34a synthesis, thus elevating sirtuin 1 (SIRT1)/eNOS synthesis in EPCs.
Kallistatin inhibits oxidative stress‐induced cellular senescence by upregulating Let‐7g synthesis, leading to modulate Let‐7g‐mediated miR‐34a‐SIRT1‐eNOS signaling pathway in human endothelial cells.
Exogenous kallistatin administration attenuates vascular injury and senescence in association with increased SIRT1 and eNOS levels and reduced miR‐34a synthesis and NADPH oxidase activity, as well as TNF‐α and ICAM‐1 expression in the aortas of streptozotocin‐ (STZ‐) induced diabetic mice.
Conversely, endothelial‐specific depletion of kallistatin aggravates vascular senescence, oxidative stress, and inflammation, with further reduction of Let‐7g, SIRT1, and eNOS and elevation of miR‐34a in mouse lung endothelial cells.
Furthermore, systemic depletion of kallistatin exacerbates aortic injury, senescence, NADPH oxidase activity, and inflammatory gene expression in STZ‐induced diabetic mice.
These findings indicate that endogenous kallistatin displays a novel role in protection against vascular injury and senescence by inhibiting oxidative stress and inflammation.

Related Results

Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis
Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis
Abstract Introduction Kallistatin levels in the circulation are reduced in patients with sepsis and liver disease. Transgenic mice expressing kallis...
Kallistatin attenuates endothelial senescence by modulating Let‐7g‐mediated miR‐34a‐SIRT1‐eNOSpathway
Kallistatin attenuates endothelial senescence by modulating Let‐7g‐mediated miR‐34a‐SIRT1‐eNOSpathway
AbstractKallistatin, a plasma protein, protects against vascular and organ injury. This study is aimed to investigate the role and mechanism of kallistatin in endothelial senescenc...
Kallistatin Inhibits Vascular Inflammation by Antagonizing Tumor Necrosis Factor-α–Induced Nuclear Factor κB Activation
Kallistatin Inhibits Vascular Inflammation by Antagonizing Tumor Necrosis Factor-α–Induced Nuclear Factor κB Activation
Kallistatin is a plasma protein with anti-inflammatory properties. In this study, we investigated the role and mechanisms of kallistatin in inhibiting endothelial inflammation thro...
Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress
Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress
AbstractKallistatin, via its two structural elements – an active site and a heparin-binding domain – displays a double-edged function in angiogenesis, apoptosis and oxidative stres...
Protective role of kallistatin in renal fibrosis via modulation of Wnt/β-catenin signaling
Protective role of kallistatin in renal fibrosis via modulation of Wnt/β-catenin signaling
Abstract Kallistatin is a multiple functional serine protease inhibitor that protects against vascular injury, organ damage and tumor progression. Kallistatin treatm...
Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis
Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis
SummaryKallistatin, a plasma protein, has been shown to exert multi‐factorial functions including inhibition of inflammation, oxidative stress and apoptosis in animal models and cu...
Salutary Effect of Kallistatin in Salt-Induced Renal Injury, Inflammation, and Fibrosis via Antioxidative Stress
Salutary Effect of Kallistatin in Salt-Induced Renal Injury, Inflammation, and Fibrosis via Antioxidative Stress
An inverse relationship exists between kallistatin levels and salt-induced oxidative stress in Dahl-salt sensitive rats. We further investigated the role of kallistatin in inhibiti...

Back to Top